Factory supply Gatifloxacin

Product Name: Gatifloxacin

CAS No. 160738-57-8

Molecular Formula: C22H28FN3O7

Molecular Weight: 465.47

Specification: 99%

Appearance:White Powder

 
Gatifloxacin is a new fluoroquinolone antimicrobial drug. Its 3-methyl-1-guazinyl group and one methoxy group characteristic structure make it have broader spectrum antimicrobial activity. It has better antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and anaerobic bacteria. Its antimicrobial activity against Staphylococcus, Streptococcus and Enterococcus is is similar to Sparfloxacin and is superior to ciprofloxacin. Star and ofloxacin have the same effects on Enterobacteriaceae and Haemophilus influenzae as ciprofloxacin.

FUCTION
For the treatment of moderate or more infectious diseases caused by sensitive strains:

1. Acute attack of chronic bronchitis: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus.

2. Acute sinusitis: caused by Streptococcus pneumoniae and Haemophilus influenzae.

3. Community acquired pneumonia: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila, Legionella pneumophila, etc.

4. Simple or complex urinary tract infection (cystitis): caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc.

5. Pyelonephritis: caused by Escherichia coli, etc.

6. Simple urethral and cervical gonorrhea: caused by Neisseria gonorrhoeae.

7. Acute simple rectal infection in women: caused by Neisseria gonorrhoeae.